Cryptech World, an investment firm acquired by private equity investor Berkeley Assets in June last year, is on a mission to bring blockchain and cryptocurrencies to retail investors.  »

Luxembourg’s funds industry enjoyed a good period of growth last year, a period during which assets under management grew, on average by 15 per cent, asset flows grew by 5 per cent, profits grew by 10 per cent, while margins were broadly maintained somewhere close to 37 per cent.  »

New York-based Blue Ox Healthcare Partners (Blue Ox) is a private equity investment firm providing capital to growth stage healthcare companies. The firm focuses on businesses in the middle market targeting the industry’s transformation to individuality and value-based care in healthcare services, HCIT, and medical and life sciences technologies, whose innovations, strategies and operations are poised for growth. »

Replay this Global Fund Media webinar – “racking the Next Gen of Liquid Alts: Private Equity – which was held in partnership with Gemini, to hear expert panelists explain how their investment vehicles provide investors with private equity exposure… »

Following the initial boom of liberalisation, new restrictions are having a severe cooling effect on the nascent international Chinese PERE market – fund managers that are in it for the long-haul will need to up their game during this period of tightening, writes Jimmy Leong, Managing Director in Asia, at Augentius.  »

Natural language processing (NLP) is changing the way humans interact with machines in ways that were unthinkable a decade ago. Thanks to huge advances in machine learning, driven and supported by ever-faster computer processing, we are increasingly using NLP tools such as Amazon Alexa, Siri, Google assistant, Cortana, Bixby, and interacting with chatbots from our service providers.  »

Impact investing has not always been the easiest ‘investment philosophy’ to benchmark, in terms of improving the health of the planet, and those who live on it, while also generating positive returns for investors. But one such fund, the New York-based Global Health Investment Fund (GHIF) is doing just that, financing the development of drugs, vaccines, diagnostics and other interventions to improve maternal and child healthcare in the developing world. »